Side Effects of COVID-19 Vaccines Among Diabetic Subjects and Healthy Individuals

被引:10
作者
Khan, Fareena [1 ]
Khan, Muhammad Taimur [2 ]
Zaman, Sana [3 ]
Mujtaba, Sadaf [4 ]
Batool, Aeliya [5 ]
Ghanghro, Zohra [6 ]
Anwar, Adnan [7 ]
Hashmi, Atif A. [8 ]
机构
[1] Baqai Med Univ, Anaesthesia, Karachi, Pakistan
[2] Standish Med Practice, Family Med, Standish, England
[3] Alastair Ross Med Practice, Family Med, Bolton, England
[4] Hamza Med Ctr & Pharm, Pharmacol & Therapeut, Karachi, Pakistan
[5] Karachi Med & Dent Coll, Pharmacol, Karachi, Pakistan
[6] South City Hosp, Paediat, Karachi, Pakistan
[7] Hamdard Coll Med & Dent, Physiol, Karachi, Pakistan
[8] Liaquat Natl Hosp & Med Coll, Pathol, Karachi, Pakistan
关键词
fever; pain; side effects; diabetes; vaccines; covid-19; MORTALITY; SEVERITY; MELLITUS; DISEASE; TYPE-1;
D O I
10.7759/cureus.36005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Vaccinations protect against disease through various ways, but the process of developing immunity might result in side effects. This study determined the immediate side effects of coronavirus disease 2019 (COVID-19) vaccination among patients with diabetes and non-diabetic participants. Methods This multi-center, cross-sectional study was conducted in multiple hospitals in Karachi, Pakistan. The duration of the study was six months, from March 1, 2022, to August 31, 2022. A total of 1150 participants who received one of the COVID-19 vaccines, for instance, Sinopharm, AstraZeneca, Sinovac, and Pfizer (double or booster doses) were included in the study and allocated into two groups: diabetics (n=540) and non-diabetics (n=610). The chi-square test was used to compare the frequency of side effects between diabetic and non-diabetic participants. The association between means of demographic variables such as age and weight was compared using an independent t-test. Results The study findings showed that the mean age of the group with diabetes was 46.73??14.98 years and that of the non-diabetic group was 44.01??14.80 years with a significant difference between them (p=0.002). The majority of participants, 187 (34.6%) patients with diabetes received Pfizer, while 234 (38.4%) non-diabetic participants received Sinovac. Following the first dose, side effects were higher in patients with diabetes. Burning at the injection site, fever, and pain were the most commonly reported side effects in patients with diabetes following the first dose. Additionally, following the second dose, burning at the injection site, muscular pain, fever, and pain were the most commonly observed side effects, with a significant association among diabetic and non-diabetic participants (p<0.001). Conclusion Diabetes is a prevalent comorbidity in individuals infected with COVID-19, and patients with diabetes report more side effects from immunization than non-diabetic participants. The most commonly reported side effects of the vaccine in diabetic participants were observed to be burning at the injection site, fever, muscle and joint pain, and swelling at the injection site. Additionally, participants with and without diabetes reported feeling satisfied with their vaccines.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] Evaluation of adverse effects with COVID-19 vaccination in Pakistan
    Abbas, Sana
    Abbas, Beenish
    Amir, Sidra
    Wajahat, Mehreen
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (07) : 1959 - 1964
  • [2] COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia
    Aldossari, Khaled K.
    Alharbi, Mashael B.
    Alkahtani, Sultan M.
    Alrowaily, Talal Z.
    Alshaikhi, Abdulmajeed M.
    Twair, Abdullah A.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (05)
  • [3] A survey on COVID-19 vaccine acceptance and concern among Malaysians
    Alwi, S. A. R. Syed
    Rafidah, E.
    Zurraini, A.
    Juslina, O.
    Brohi, I. B.
    Lukas, S.
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)
  • [4] Relationship between blood clots and COVID-19 vaccines: A literature review
    Atyabi, Seyed Mohammad Hassan
    Rommasi, Foad
    Ramezani, Mohammad Hossein
    Ezabadi, Mohammad Fazel Ghane
    Arani, Mehdi AghaAmooi
    Sadeghi, Mohammad Hossein
    Ahmed, Mohammad Mehdi
    Rajabi, Amir
    Dehghan, Nima
    Sohrabi, Ali
    Seifi, Mojtaba
    Nasiri, Mohammad Javad
    [J]. OPEN LIFE SCIENCES, 2022, 17 (01): : 401 - 415
  • [5] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Baden, Lindsey R.
    El Sahly, Hana M.
    Essink, Brandon
    Kotloff, Karen
    Frey, Sharon
    Novak, Rick
    Diemert, David
    Spector, Stephen A.
    Rouphael, Nadine
    Creech, C. Buddy
    McGettigan, John
    Khetan, Shishir
    Segall, Nathan
    Solis, Joel
    Brosz, Adam
    Fierro, Carlos
    Schwartz, Howard
    Neuzil, Kathleen
    Corey, Larry
    Gilbert, Peter
    Janes, Holly
    Follmann, Dean
    Marovich, Mary
    Mascola, John
    Polakowski, Laura
    Ledgerwood, Julie
    Graham, Barney S.
    Bennett, Hamilton
    Pajon, Rolando
    Knightly, Conor
    Leav, Brett
    Deng, Weiping
    Zhou, Honghong
    Han, Shu
    Ivarsson, Melanie
    Miller, Jacqueline
    Zaks, Tal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) : 403 - 416
  • [6] Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
    Barron, Emma
    Bakhai, Chirag
    Kar, Partha
    Weaver, Andy
    Bradley, Dominique
    Ismail, Hassan
    Knighton, Peter
    Holman, Naomi
    Khunti, Kamlesh
    Sattar, Naveed
    Wareham, Nicholas J.
    Young, Bob
    Valabhji, Jonathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) : 813 - 822
  • [7] COVID-19 vaccine acceptance among high-risk populations in Uganda
    Bongomin, Felix
    Olum, Ronald
    Andia-Biraro, Irene
    Nakwagala, Frederick Nelson
    Hassan, Khalid Hudow
    Nassozi, Dianah Rhoda
    Kaddumukasa, Mark
    Byakika-Kibwika, Pauline
    Kiguli, Sarah
    Kirenga, Bruce J.
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [8] Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
    Boroumand, Amir Bahador
    Forouhi, Mahtab
    Karimi, Farzaneh
    Moghadam, Arman Soltani
    Naeini, Leila Ghanbari
    Kokabian, Pajman
    Naderi, Delaram
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
    Cariou, Bertrand
    Hadjadj, Samy
    Wargny, Matthieu
    Pichelin, Matthieu
    Al-Salameh, Abdallah
    Allix, Ingrid
    Amadou, Coralie
    Arnault, Gwenaelle
    Baudoux, Florence
    Bauduceau, Bernard
    Borot, Sophie
    Bourgeon-Ghittori, Muriel
    Bourron, Olivier
    Boutoille, David
    Cazenave-Roblot, France
    Chaumeil, Claude
    Cosson, Emmanuel
    Coudol, Sandrine
    Darmon, Patrice
    Disse, Emmanuel
    Ducet-Boiffard, Amelie
    Gaborit, Benedicte
    Joubert, Michael
    Kerlan, Veronique
    Laviolle, Bruno
    Marchand, Lucien
    Meyer, Laurent
    Potier, Louis
    Prevost, Gaetan
    Riveline, Jean-Pierre
    Robert, Rene
    Saulnier, Pierre-Jean
    Sultan, Ariane
    Thebaut, Jean-Francois
    Thivolet, Charles
    Tramunt, Blandine
    Vatier, Camille
    Roussel, Ronan
    Gautier, Jean-Francois
    Gourdy, Pierre
    [J]. DIABETOLOGIA, 2020, 63 (08) : 1500 - 1515
  • [10] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
    Folegatti, Pedro M.
    Ewer, Katie J.
    Aley, Parvinder K.
    Angus, Brian
    Becker, Stephan
    Belij-Rammerstorfer, Sandra
    Bellamy, Duncan
    Bibi, Sagida
    Bittaye, Mustapha
    Clutterbuck, Elizabeth A.
    Dold, Christina
    Faust, Saul N.
    Finn, Adam
    Flaxman, Amy L.
    Hallis, Bassam
    Heath, Paul
    Jenkin, Daniel
    Lazarus, Rajeka
    Makinson, Rebecca
    Minassian, Angela M.
    Pollock, Katrina M.
    Ramasamy, Maheshi
    Robinson, Hannah
    Snape, Matthew
    Tarrant, Richard
    Voysey, Merryn
    Green, Catherine
    Douglas, Alexander D.
    Hill, Adrian V. S.
    Lambe, Teresa
    Gilbert, Sarah C.
    Pollard, Andrew J.
    [J]. LANCET, 2020, 396 (10249) : 467 - 478